Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Phase 1/2 Study of CPX-351 (NSC# 775341; IND #129443) Alone Followed by Fludarabine; Cytarabine; and G-CSF (FLAG) for Children with Relapsed Acute Myeloid Leukemia (AML)CIRB: Pediatric CIRBLead Group: COGStatus: Temporarily Closed to AccrualReview Status: Available to Open